Rps6ka6 (BC054113) Mouse Tagged ORF Clone Lentiviral Particle

CAT#: MR210274L3V

  • LentiORF®

Lenti ORF particles, Rps6ka6 (Myc-DDK-tagged) - Mouse ribosomal protein S6 kinase polypeptide 6 (cDNA clone MGC:60789 IMAGE:30015425), 200ul, >10^7 TU/mL

ORF Plasmid: DDK tGFP



Need custom lentivirus service?
Get a free quote

CNY 11,875.00


货期*
详询

规格
    • 200 ul

Product images

经常一起买 (2)
Lenti ORF control particles of pLenti-C-Myc-DDK-P2A-Puro, >1x10^7 TU/ml, 0.5 ml
    • 500 ul

CNY 2,950.00


One-Wash Lentivirus Titer Kit, HIV-1 p24 ELISA
    • 96 reactions

CNY 5,230.00

Specifications

Product Data
Product Name Rps6ka6 (BC054113) Mouse Tagged ORF Clone Lentiviral Particle
Synonyms 2610524K04Rik; RSK4; S6K-alpha-6
Vector pLenti-C-Myc-DDK-P2A-Puro
ACCN BC054113
ORF Size 2160 bp
Sequence Data
The ORF insert of this clone is exactly the same as(MR210274).
OTI Disclaimer The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
OTI Annotation This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.
Reference Data
RefSeq BC054113.1
RefSeq Size 3906 bp
RefSeq ORF 2162 bp
Locus ID 67071
Gene Summary Constitutively active serine/threonine-protein kinase that exhibits growth-factor-independent kinase activity and that may participate in p53/TP53-dependent cell growth arrest signaling and play an inhibitory role during embryogenesis.[UniProtKB/Swiss-Prot Function]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.
Customer Reviews 
Loading...